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Abstract  
The influence of low natural altitudes (< 2000 m) on erythropoi-
etic adaptation is currently unclear, with current recommenda-
tions indicating that such low altitudes may be insufficient to 
stimulate significant increases in haemoglobin mass (Hbmass). As 
such, the purpose of this study was to determine the influence of 
3 weeks of live high, train high exposure (LHTH) at low natural 
altitude (i.e. 1800 m) on Hbmass, red blood cell count and iron 
profile. A total of 16 elite or well-trained runners were assigned 
into either a LHTH (n = 8) or CONTROL (n = 8) group. Venous 
blood samples were drawn prior to, at 2 weeks and at 3 weeks 
following exposure. Hbmass was measured in duplicate prior to 
exposure and at 2 weeks and at 3 weeks following exposure via 
carbon monoxide rebreathing. The percentage change in Hbmass 
from baseline was significantly greater in LHTH, when com-
pared with the CONTROL group at 2 (3.1% vs 0.4%; p = 0.01;) 
and 3 weeks (3.0% vs -1.1%; p < 0.02, respectively) following 
exposure. Haematocrit was greater in LHTH than CONTROL at 
2 (p = 0.01) and 3 weeks (p = 0.04) following exposure. No 
significant interaction effect was observed for haemoglobin 
concentration (p = 0.06), serum ferritin (p = 0.43), transferrin (p 
= 0.52) or reticulocyte percentage (p = 0.16). The results of this 
study indicate that three week of natural classic (i.e. LHTH) low 
altitude exposure (1800 m) results in a significant increase in 
Hbmass of elite distance runners, which is likely due to the con-
tinuous exposure to hypoxia. 
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Introduction 
 
Athletes are required to spend a prolonged period of time 
at moderate altitude (2000 – 3000 m (Bartsch et al., 
2008)) in order to accumulate a sufficient total hypoxic 
“dose” to stimulate erythropoiesis (Garvican et al., 2012). 
Indeed, current guidelines for simulated altitude exposure 
suggest that athletes should spend ~ 14 h∙day-1 at 3000 m 
for 3 weeks (totalling ~ 300 hours of exposure) in order to 
observe a mean increase in haemoglobin mass (Hbmass) of 
3 – 5% (Saunders et al., 2013). Likewise, a similar re-
sponse may be achieved when 300 hours of exposure is 
accumulated at natural altitude (Garvican et al., 2012). 
Closer investigation of the time course of erythropoietic 
adaptation indicates that Hbmass increases approximately 
1% per 100 hours of exposure at simulated or natural 
altitude of 2300 to 3000 m (Clark et al., 2009; Garvican et 
al., 2012). However, achieving such altitude exposures is 
often difficult for athletes due to limited availability of 
appropriate simulated or natural altitude, decreased liv-
ing/sleeping and training quality (especially at altitudes 
above 3000 m), and interference with training or competi-
tion schedules (Neya et al., 2013).  
To date, several models of hypoxic exposure have 
been established including; live high/train high (LHTH); 
live high/train low; live low/train high (i.e. intermittent 
hypoxic exposure during training) or intermittent hypoxic 
exposure at rest (McLean et al., 2014; Millet et al., 2013; 
Millet et al., 2010 ). The possible physiological and per-
formance benefits of each of these modes of altitude ex-
posure differ considerably with contributing factors in-
cluding, normobaric vs hypobaric exposure (Saugy et al., 
2014), the total elevation of exposure and the duration of 
exposure (Gore et al., 2013). Indeed, clear relationships 
exist between the dose of altitude exposure (measured as 
total duration (Bonetti and Hopkins, 2009; Gore et al., 
2013), increases in Hbmass and/or associated improvements 
in aerobic capacity (Schmidt and Prommer, 2010).  
Natural low altitude venues attract a considerable 
number of athletes each year with the common belief that 
even ‘low’ altitude (< 2000 m) contributes favourably to 
athlete performance at sea-level (Gore et al., 2007). Sup-
porting this, three weeks of classical (LHTH) altitude 
exposure at 1300 m and 1650 m interspersed with three 
weeks of sea level training has been shown to result in an 
increase in Hbmass and erythropoietin concentration (Frese 
and Friedmann-Bette, 2010; Saunders et al., 2009). Like-
wise, four weeks of LHTH altitude exposure at 1900m 
has been reported to result an increase in left ventricular 
mass and improved aerobic capacity in six of seven elite 
skiers (Siebenmann et al., 2012). Conversely, current 
scientific recommendations would suggest that natural 
altitude exposure below (< 2000 m) is too low to stimu-
late significant erythropoietic benefit (Pottgiesser et al., 
2009; Wilber, 2007). Despite this, little is known as to the 
minimal hypoxic dose required for erythropoiesis and 
thus the mechanism responsible for a possible increase in 
performance with low altitude is unclear. Indeed, current 
literature suggests that a minimum of two weeks of clas-
sic altitude exposure above 2100 m is required in order to 
observe improvements in Hbmass (Gore et al., 2013). 
It is plausible that improvements in performance 
following altitude exposure may be associated with al-
tered training or the favourable belief that altitude training 
has been successful, rather than haematological altera-
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tions. Indeed, it has been suggested that placebo effects 
and/or a better training environment (i.e. high-quality 
training camps, increased focus on training and recovery, 
less distractions, change of venue, and people to train 
with on a consistent basis) may be responsible for some of 
the improvements in performance observed within alti-
tude exposure research (Saunders et al., 2009; 2010; 
Siebenmann et al., 2012). Clearly, further research is 
warranted in order to examine the possible haematologi-
cal alterations of low altitude exposure in order to assess 
the effectiveness of such exposure. As such, the aim of 
the present study was to examine the effects of 3 weeks of 
live high, train high exposure (LHTH) at low natural 
altitude (i.e. Perisher Valley, 1800 m) on Hbmass, red 
blood cell count and iron profile in elite distance runners.  
 
Methods 
 
Participants 
Sixteen elite or well-trained male and female distance 
runners were recruited from national and state sporting 
organisations and allocated into two groups (Table 1). 
These two groups comprised of participants that slept and 
trained at low altitudes (LHTH, n = 8) or remained near 
sea level for a period of 3 weeks (CONTROL, n = 8). All 
participants were provided with the procedures and risks 
associated with their participation in this study. Prior to 
data collection, written informed consent was obtained in 
accordance with the institution’s Human Research Ethics 
Committee. All athletes were in a “pre-competition” 
phase meaning they were preparing to race in national and 
international track races following the winter build-up 
period. Therefore, all runners had significant prior aerobic 
conditioning, their training volume was high and included 
both threshold based interval sessions and some race 
specific interval sessions. Throughout the study, training 
intensity, duration and frequency were controlled by ex-
ternal coaches but athletes and coaches were asked not to 
substantially alter their training schedules during the 
study period. 
 
Table 1. Characteristics and weekly training of participants 
in the live high, train high (LHTH) altitude exposure and 
control groups. Values are mean (±SD). 
 Live High : Train 
High(n=8) 
Control 
(n=8) 
Male / Female 8 male 3 female, 5 male 
Age (y) 22.0 (3.7) 25.9 (5.2) 
Mass (kg) 68.0 (5.4) 62.8 (8.3) 
Hbmass (g) 933 (131) 839 (196) 
Relative Hbmass (g∙kg-1) 13.6 (1.1) 13.2 (1.8) 
Weekly TR Vol (km.wk-1) 86.2 (14.6) 100.2  (20.4) 
The training volumes (TR Vol) are those completed during the interven-
tion. 
 
Procedures 
The LHTH group, lived at a natural altitude of 1800 m 
(Perisher Valley, New South Wales, Australia) and 
trained at altitudes of 1700 to 2200 m (Snowy Mountains, 
Australia). Twice a week, these athletes also descended to 
1000 m to perform high intensity training sessions (~2h) 
on  a  synthetic athletics track or running trails. The CON- 
TROL group lived and trained near sea level for the dura-
tion of the study (Canberra, 600 m). All athletes were 
supplemented with oral iron (Ferro-Grad C, Abbott La-
boratories, 105g elemental iron) on a daily basis to ensure 
any erythropoietic adaptations were not compromised by 
insufficient iron availability. At baseline, after two weeks 
and again at completion of the three-week intervention, 
haemoglobin mass (Hbmass) was assessed and a venous 
blood sample was taken from all participants. 
Hbmass was measured using the 2-min carbon mon-
oxide (CO) rebreathing method as described by Schmidt 
and Prommer (2005) with some modifications (Alexander 
et al., 2011; Garvican et al., 2010; Prommer and Schmidt, 
2007). Briefly, participants rebreathed a CO bolus equiva-
lent to 1.2 ml.kg-1 of body weight for a period of two 
minutes. Capillary blood samples were obtained at the 
start of the test as well as at seven minutes post admin-
istration of the CO dose for determination of the percent-
age of bound carboxyhaemoglobin (%HbCO). Blood 
samples were measured a minimum of five times for 
%HbCO using an OSM3 hemoximeter (Radiometer, Co-
penhaen). The same analyser was used for all tests per-
formed. Expired CO was determined using a Drӓger Pac 
7000 (Lübeck, Germany) CO sensor. Hbmass was calculat-
ed from the mean change in %HbCO before and after 
rebreathing. Hbmass was measured in duplicate at baseline 
and the typical error of measurement for Hbmass, calculat-
ed from these double baseline measures was 1.4% (90% 
confidence limits; 1.0 to 2.2). 
Venous blood samples were drawn by trained 
phlebotomists from an antecubital forearm vein and ana-
lysed within 12 to 24 h. Samples collected at 1800 m were 
transported at 10°C and analysed in the same laboratory 
as all other samples. On each occasion, 2 ml of whole 
blood was collected into an EDTA vacutainer for meas-
urement of haemoglobin concentration [Hb], haematocrit 
(Hct), and reticulocytes (%retics) (Sysmex XT-2000i; 
Sysmex Corporation, Japan). A further 4 ml was collected 
into a serum vacutainer to assess serum ferritin, soluble 
iron, transferrin and percent transferrin saturation (CO-
BAS INTEGRA 400 plus, Roche Diagnostics, Switzer-
land). A total of 18 ml of whole blood was obtained over 
the course of the study, and thus likely to have had negli-
gible effects on changes in Hbmass since this volume 
amounts to a loss of ~3 g of Hb. 
 
Statistical analysis  
Participants’ age, body mass and pre-exposure HBmass 
were compared between groups using an independent 
sample t-test. Changes in serum ferritin, reticulocytes, 
transferrin, haemoglobin, haematocrit and the percent 
change in Hbmass were compared between Conditions and 
over Time using a mixed model two-way ANOVA. 
Where significant effects were observed Tukey post hoc 
tests were used. Assumptions of sphericity (Mauchly’s 
test) were assessed. Where violations to assumptions of 
sphericity where observed, the degrees of freedom were 
corrected using Greenhouse-Geisser or Huynh-Feldt cor-
rections where appropriate. The critical level of signifi-
cance was set at p ≤ 0.05.  
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Figure 1. Percentage change in Hbmass from baseline following three weeks of live high, train high (LHTH; A 
and C) altitude exposure or training and living near sea-level (600m; B and D) group. Mean and standard deviation 
shown in black, with individual data shown in grey. * p < 0.05, compared with CONTROL. 
 
Results 
 
Age, body mass, as well as pre-exposure Hbmass were not 
significantly different between LHTH and CONTROL 
(Table 1). All subjects in the CONTROL group complet-
ed the 3 weeks of prescribed training. In the LHTH group, 
8 subjects completed 2 weeks but due to personal com-
mitments only 5 subjects completed the entire 3 weeks of 
exposure. The increase in Hbmass from baseline was signif-
icantly greater in LHTH, compared with CONTROL, at 
both 2 (P=0.01) and 3 weeks (p = 0.02) following expo-
sure (Figure 1).  
 A significant interaction effect was observed for 
Condition and Time in Hct (p < 0.01; Table 2). Post hoc 
comparisons revealed that Hct was greater in LHTH than 
CONTROL at 2 (p = 0.01) and 3 weeks (p = 0.04) of 
exposure (Table 2). Reticulocyte count was significantly 
greater in LHTH compared with CONTROL at 2 (p = 
0.02) but not at 3 weeks (p = 0.27) of exposure. No signif-
icant interactions were observed for [Hb] (P=0.06), serum 
ferritin (p = 0.43), transferrin (p = 0.52) or reticulocyte 
expressed as a percentage (p = 0.16).  
Discussion 
 
The present study found that 3 weeks of LHTH (i.e. clas-
sic) altitude exposure at just 1800 m was sufficient to 
induce a significant increase in Hbmass in elite distance 
runners. This finding is of interest because it is generally 
considered that natural altitude exposure below 2000 m is 
insufficient to stimulate significant erythropoietic benefit 
(Pottgiesser et al., 2009; Wilber, 2007).  
We observed a 3.0% increase in Hbmass following three 
weeks of LHTH altitude exposure at 1800 m. This signifi-
cant increase in Hbmass was also associated with an in-
crease in reticulocyte count and Hct, compared with the 
CONTROL group, within the first two weeks of the 
LHTH altitude exposure. Such an increase in Hbmass is 
somewhat consistent with previous research showing that 
three weeks of classical altitude training at 1300 m and 
1650 m interspersed with three weeks of sea level training 
resulted in an increased red blood cell volume, Hbmass and 
serum EPO concentration (Frese and Friedmann-Bette, 
2010). But, our results are contrary to those of Rasmussen 
et al. (2013), who concluded from a comprehensive
 
Table 2.  Serum ferritin, reticulocytes, transferrin, haemoglobin and haematocrit of participants at baseline and following 
three weeks of live high, train high (LHTH) altitude exposure or training and living near sea-level (600m; CONTROL) 
group. Data are means (±SD). 
 LHTH (1800 m) Control (600 m) 
 Baseline 2 Weeks 3 Weeks Baseline 2 Weeks 3 Weeks 
Serum Ferritin  (µg/L) 91.3 (60.0) 81.4 (42.0) 82.4 (37.5) 84.4 (43.4) 88.3 (41.5) 118.8 (79.6) 
Reticulocytes (x 109/L) 37.2 (10.8) 58.3 (17.3) * 52.5 (16.4) 38.2 (9.3) 40.7 (7.7) 43.7 (9.9) 
Reticulocytes (%) .94 (.25) 1.09 (.30) 1.01 (.33) 1.10 (.20) 1.13 (.22) 1.19 (.26) 
Haemoglobin Concentration (g/dL) 15.4 (.9) 15.9 (.7) 15.6 (.9) 14.8 (1.2) 14.6 (1.0) 14.4 (1.3) 
Transferrin (g/L) 2.81 (.37) 2.84 (.40) 2.7 (.56) 2.89 (.21) 2.87 (.15) 2.76 (.25) 
Hematocrit (%) 44.2 (2.1) 45.1 (1.8) * 45.3 (2.3) * 42.4 (2.9) 41.7 (2.9) 41.1 (3.7) 
* p < 0.05, significantly different to CONTROL. 
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meta-analysis that exposure to natural altitude must ex-
ceed two weeks at 4000 m to observe a statically signifi-
cant effect. On the other hand, our findings also support 
the recent conclusions surrounding the time course of 
erythropoietic adaptation of a 1% increase per 100 hours 
of exposure when exposed to either natural or simulated 
moderate altitudes (Clark et al., 2009; Garvican et al., 
2012). A recent meta-analysis by Gore et al., (2013) ex-
amined Hbmass changes following a variety of hypoxic 
doses (including LHTH studies ranging from 10-28 days) 
and determined that during altitude exposure Hbmass in-
creased at a rate of ~1.1% per 100 hours for both LHTH 
and live-high train-low altitude exposure; with the re-
sponse at 2200 m natural altitude being just as effective as 
at 3000 m simulated altitude provided the total hours of 
exposure are matched. Notably, within the present study, 
the majority of the increase in Hbmass was observed within 
the first two weeks of altitude exposure (Figure 1). The 
meta-analysis of Gore et al. (2013), predicts an additional 
~2% increase in Hbmass in the third week, which was not 
observed. Regardless, our current results identify 1800 m 
as a suitable threshold altitude for LHTH for increased 
red blood cell production and also reinforce the efficacy 
of LHTH since it provides continuous exposure to hypox-
ia.  
Given that the present study examined low altitude 
exposure, it is also salient to examine the total hypoxic 
dose as calculated by hours of exposure multiplied by 
altitude height. Within this study the LHTL group accu-
mulated 336 hours of exposure at 1800 m after 2 weeks 
and 504 h after 3 weeks, which equates to 604,800 AU 
and 907,200 AU, respectively. Interestingly, the recent 
study of Ryan et al. (2014) reported a 3.7% increase in 
Hbmass after 7 days at 5260 m, which equates to 883,680 
AU, with the magnitude of increase in Hbmass somewhat 
comparable to the 3.0% increase for 907,200 AU ob-
served in this study. It should be noted that this conceptu-
al model for the determination of hypoxic dose assumes 
linear relationships between changes in Hbmass and in-
creasing altitude height or duration of exposure. While 
this is unlikely, this model improves on previous models 
quantifying altitude dose which typically focus on the 
duration of exposure alone (Gore et al., 2013). Clearly, 
further research is needed in order to better understand the 
the dose-response relationship of Hbmass at altitude, along 
with titrating the minimally effective altitude. Indeed, 
with training intensities even less compromised, it may be 
beneficial to examine Hbmass responses at even lower 
altitudes (1300-1600 m) (Frese and Friedmann-Bette, 
2010) for athletes who only have access to such low lying 
altitudes venues.  
 
Limitations of the study 
Although planned, performance data are unavailable for 
this study due to the timing of altitude exposure and ath-
lete’s specific training and racing schedules. Due to un-
foreseen circumstances some athletes could not and did 
not race as planned on their return to sea level while oth-
ers engaged in a consecutive bout of altitude training a 
few weeks following this study and thus due to a number 
of confounding variables affecting individual results a 
true measure of performance could not be formulated. 
However, our group has previously acknowledged the 
challenges of demonstrating that small changes in Hbmass 
translate in to a performance benefit (Gore, 2014). 
 
Conclusion 
 
The results of this study have illustrated that it is possible 
for athletes to expect a ~ 3% increase in Hbmass after only 
14 days of LHTH training at 1800 m. This lowers by 
~200 m the threshold altitude considered sufficient to 
increase red blood cell production. Given the that acceler-
ated red blood production seems to depend on the total 
dose of sufficient ‘altitude’ our results highlight that 
LHTH is the most time efficient modality for athletes and 
coaches to consider, because it provides 24 hour per day 
exposure to hypoxia, provided that sufficient total hours 
can be accumulated. 
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Key points 
 
• Two and three weeks of LHTH altitude exposure 
(1800 m) results in a significant increase in Hbmass 
• LHTH altitude exposure increased Hbmass by 3.1% 
after 2 weeks, and 3.0% after 3 weeks of exposure 
• LHTH altitude exposure may be a practical method 
to increase Hbmass in well-trained athletes. 
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